Use of tenofovir disoproxil fumarate and emtricitabine combination in HIV-infected patients

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.7, Iss.6, 2006-04, pp. : 793-802

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emtricitabine/Tenofovir Disoproxil Fumarate: In Combination with a Protease Inhibitor in HIV-1 Infection

By Perry Caroline M.

Drugs, Vol. 69, Iss. 7, 2009-05 ,pp. : 843-857

Adis International

Access to resources Recommend Favorite

A new drug combination therapy for treatment-naive patients with HIV-1 infection, consisting of raltegravir, emtricitabine and tenofovir disoproxil fumarate

By Clercq Erik De

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 17, 2009-12 ,pp. : 2935-2937

Informa Healthcare

Access to resources Recommend Favorite

Emtricitabine/Tenofovir Disoproxil Fumarate

By Adis International Limited

Drugs in R&D, Vol. 5, Iss. 3, 2004-01 ,pp. : 160-161

Adis International

Access to resources Recommend Favorite

Emtricitabine/Tenofovir Disoproxil Fumarate

By Toni M. Dando Antona J. Wagstaff

Drugs, Vol. 64, Iss. 18, 2004-01 ,pp. : 2075-2082

Adis International

Access to resources Recommend Favorite

Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate: Triple Combination Tablet

By Frampton James E. Croom Katherine F.

Drugs, Vol. 66, Iss. 11, 2006-01 ,pp. : 1501-1512

Adis International

Access to resources Recommend Favorite